The social-media giant made its public debut in March and has been finding life post-IPO to be surprisingly fruitful.
Despite the slow market thaw in recent years, 18 biotech companies have priced out IPOs through September 2024, but going ...
Bain Capital has a tricky job on its hands. The private equity firm is set to list Japanese memory-chip maker Kioxia six ...
HYBE chairman Bang Si-hyuk is being investigated by Korean regulators over over allegations he made $285 million from the ...
Suraksha Diagnostics IPO concludes with full subscription, driven by strong QIB interest. Key dates include allotment on ...
Smithfield Foods Inc. will transfer part of its hog farming operations to a new venture controlled by Murphy Family Ventures ...
The IPO market has been sluggish in the last few years. Lower interest rates could unleash a wave of new activity. Given the ...
The IPO consists of solely fresh issue of 26.04 lakh shares by the company, with no offer-for-sale component. The public ...
Plans are advancing for an initial public offering of Citigroup Inc.’s Banamex business in Mexico after the bank finished ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback